Article
Global variation in the SARS-CoV-2 proteome reveals the mutational hotspots in the drug and vaccine candidates
2020-07-31
Abstract excerpt
<h4>ABSTRACT</h4> To accelerate the drug and vaccine development against the severe acute respiratory syndrome virus 2 (SARS-CoV-2), a comparative analysis of SARS-CoV-2 proteome has been performed in two phases by considering manually curated 31389 whole genome sequences from 84 countries. Among the 9 mutations that occur at a high significance (T85I-NPS2, L37F-NSP6, P323L-NSP12, D614G-spike, Q57H-ORF3a, G251V-O...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8c72834-34d6-5267-8169-3519531bf904
- DOI
- 10.1101/2020.07.31.230987
